Effect of Glucose 5% on Labor Length

NCT ID: NCT04492150

Last Updated: 2020-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

476 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-09

Study Completion Date

2020-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Induction of labor, is one of the most common obstetric procedures done routinely in modern obstetrics. For example, in USA, 23% of pregnant women in 2012 (about 1 million) underwent an induction of labor. However, accurate data about percentage of women undergoing induction of labor in Egypt is not accurately known.

One of the recent research era in current obstetrics is the optimal intravenous (IV) hydration of the pregnant women in labor.Current evidences available in our hands, suggest that maternal hydration appears to fasten labor progress and enhance the action of oxytocin, if the later is used for augmentation. However, the addition of glucose supplementation to this IV hydration to enhance uterine contraction, as a matter of safety and efficacy, is controversial

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Induction of Labor Affected Fetus / Newborn

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

women who will receive 250 mL/hour of dextrose 5% with normal saline in a 1:1 ratio.

Group Type EXPERIMENTAL

Dextrose 5%/Nacl 0.3% Inj_#3

Intervention Type DRUG

250 mL/hour of dextrose 5% intravenous drip

Saline

Intervention Type DRUG

250 mL/hour of normal saline intravenous drip

control group

women who will receive 250 mL/hour of normal saline for the whole duration of induction

Group Type ACTIVE_COMPARATOR

Saline

Intervention Type DRUG

250 mL/hour of normal saline intravenous drip

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dextrose 5%/Nacl 0.3% Inj_#3

250 mL/hour of dextrose 5% intravenous drip

Intervention Type DRUG

Saline

250 mL/hour of normal saline intravenous drip

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (\>18 years) multiparous women
* Late Term Pregnancy ( gestational Age Between 40-42 weeks)
* Uncomplicated singleton pregnancy with cephalic presentation.
* Favorable cervix for induction (Bishop score\<6) without ruptured membranes.

Exclusion Criteria

* Women with chronic diseases or complicated pregnancy; gestational and pre gestational ( type 1 \& 2)diabetes, preeclampsia and\\or renal and\\or maternal heart diseases.
* Non-cephalic presentations, multiple pregnancies, or cervix unfavorable for induction.
* Other indications for cesarean delivery
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Suez Canal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Salwa Hussein Ismaeil Tammam

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zakia M Ibraheim, MD

Role: STUDY_CHAIR

Professor of Gynecology and Obstetrics

Mariam L Mohammed, MD

Role: STUDY_DIRECTOR

Assistant Professor of Gynecology and Obstetrics

Hanan M Ghoneim, MD

Role: STUDY_DIRECTOR

Assistant Professor of Gynecology and Obstetrics

Ahmed M Abbas, MD

Role: STUDY_DIRECTOR

Assistant Professor of Gynecology and Obstetrics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Suez canal University

Ismailia, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Salwa H Tammam, M. B. B. Ch

Role: CONTACT

00201012869258

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Salwa Hussein, MMBCh

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexamethasone and Induction of Delivery
NCT03658590 COMPLETED PHASE1
Intrapartum Hydration
NCT01242293 COMPLETED NA